Grant Number:	5R01CA104459-06 Interpret this number
Primary Investigator:	Imperiale, Thomas
Organization:	Indiana Univ-Purdue Univ At Indianapolis
Project Title:	Quantifying Risk to Target Screening Colonoscopy
Fiscal Year:	2009

DESCRIPTION (provided by applicant): Despite calls for universal colonoscopy (CY) for colorectal cancer (CRC) screening, its clinical application will be limited by issues of cost, safety, constrained resources, and patient acceptance. A method to quantify risk for CRC and advanced, pre-malignant polyps (collectively known as "advanced neoplasia") could allow use of different screening tests (CY, sigmoidoscopy, fecal occult blood) to be tailored to risk. While epidemiological studies had demonstrated associations between several phenotypic and environmental factors and the risks for CRC and polyps, whether these factors can be used in combination to estimate and stratify individual patient risk has not been determined. The objective of this research is to create a system to quantify risk for advanced neoplasia (AN) in average risk persons; the long-term goal is to improve the efficiency and cost-effectiveness of CRC screening. Using the clinical sites for two employer-based programs of screening CY, one of which has already produced important research about CRC screening, we propose to establish a research infrastructure and blood (serum and DNA) repository. Building on our preliminary work, we will collect detailed and reliable data prospectively from 6,000 average-risk persons undergoing first-time screening CY. One week prior to CY, patients will receive a survey in the mail to measure demographic, clinical, familial, and lifestyle (diet, exercise, medication use, etc.) factors. Research assistants may assist patients with the survey by telephone. Physical measures and blood specimen donation will be obtained by trained clinical personnel immediately prior to CY. Endoscopic and histological data will be collected following CY. Using methods of multivariable analysis to identify features that predict risk for AN, we will derive two clinical prediction rules (CPRs) to stratify risk for AN 1) anywhere in the large intestine--to target the timing and intensity of initial screening, and; 2) in the proximal colon--to target use of CY after sigmoidoscopy. The hypothesis for this research, supported by our preliminary data, is that risk factors from epidemiological studies may be used to create CPRs that quantify risk for AN and thus, to tailor CRC screening. This project will 1) be the largest study of community-based screening CY in men and women; 2) measure comprehensively and test simultaneously the predictive value of multiple risk factors for colorectal neoplasia; 3) establish CPRs based on these factors, and 4) establish a serum and DNA repository for future analysis of serum markers and genetic profiles that may refine the ability to stratify individual risk. Attaining these objectives will allow tailoring of initial CRC screening according to risk, with targeted use of CY among higher-risk persons, and reduction of unnecessary CY for very low-risk persons. The knowledge generated by this research will help maximize prevention and minimize the morbidity and cost of CRC screening.




New scoring systems for predicting advanced proximal neoplasia in asymptomatic adults with or without knowing distal colorectal findings: a prospective, cross-sectional study.
Authors: Imperiale T.F. , Monahan P.O. , Stump T.E. , Ransohoff D.F. .
Source: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2022-07-01; 31(4), p. 318-325.
EPub date: 2021-09-17.
PMID: 34545024
Related Citations

Derivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adults.
Authors: Imperiale T.F. , Monahan P.O. , Stump T.E. , Ransohoff D.F. .
Source: Gut, 2021 Jun; 70(6), p. 1155-1161.
EPub date: 2020-09-29.
PMID: 32994311
Related Citations

Risk of Advanced Neoplasia Using the National Cancer Institute's Colorectal Cancer Risk Assessment Tool.
Authors: Imperiale T.F. , Yu M. , Monahan P.O. , Stump T.E. , Tabbey R. , Glowinski E. , Ransohoff D.F. .
Source: Journal of the National Cancer Institute, 2017 Jan; 109(1), .
EPub date: 2016-08-31.
PMID: 27582444
Related Citations

Advanced colorectal neoplasia risk stratification by penalized logistic regression.
Authors: Lin Y. , Yu M. , Wang S. , Chappell R. , Imperiale T.F. .
Source: Statistical methods in medical research, 2016 Aug; 25(4), p. 1677-91.
EPub date: 2013-07-30.
PMID: 23907780
Related Citations

Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study.
Authors: Imperiale T.F. , Monahan P.O. , Stump T.E. , Glowinski E.A. , Ransohoff D.F. .
Source: Annals of internal medicine, 2015-09-01; 163(5), p. 339-46.
PMID: 26259154
Related Citations

Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia.
Authors: Imperiale T.F. , Glowinski E.A. , Lin-Cooper C. , Ransohoff D.F. .
Source: The American journal of medicine, 2012 Dec; 125(12), p. 1181-7.
EPub date: 2012-10-09.
PMID: 23062404
Related Citations

Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review.
Authors: Imperiale T.F. , Ransohoff D.F. .
Source: Annals of internal medicine, 2012-05-15; 156(10), p. 703-9.
PMID: 22586009
Related Citations

Screening for colorectal cancer in the elderly population: how much is enough?
Authors: Imperiale T.F. .
Source: Archives of internal medicine, 2011-08-08; 171(15), p. 1332-4.
PMID: 21824947
Related Citations

The average-risk age threshold for colorectal cancer screening: should it be lowered?
Authors: Imperiale T.F. .
Source: Digestive diseases and sciences, 2011 May; 56(5), p. 1249-51.
PMID: 21360278
Related Citations

Continue or discontinue warfarin for fecal occult blood testing in 2010? Does the published evidence provide an answer?
Authors: Imperiale T.F. .
Source: The American journal of gastroenterology, 2010 Sep; 105(9), p. 2036-9.
PMID: 20818354
Related Citations

Understanding differences in the guidelines for colorectal cancer screening.
Authors: Imperiale T.F. , Ransohoff D.F. .
Source: Gastroenterology, 2010 May; 138(5), p. 1642-1647.e1.
EPub date: 2010-03-16.
PMID: 20302867
Related Citations

Toward risk stratification for screening and surveillance of colorectal neoplasia: one small step for the colonoscopist.
Authors: Imperiale T.F. .
Source: Gastroenterology, 2007 Oct; 133(4), p. 1364-7.
PMID: 17919505
Related Citations